SNX281   Click here for help

GtoPdb Ligand ID: 12011

Compound class: Synthetic organic
Comment: SNX281 is a systemically active stimulator of interferon genes (STING) agonist, that was developed to induce anti-tumour immunity [1]. SNX281 is competitive with the endogenous cyclic dinucleotide STING agonist 2'3'-cGAMP. Analysis reveals that SNX281 self-dimerises to generate a structure that is large enough to occupy STING's cyclic dinucleotide binding site, which switches the protein to its active state conformation.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 84.6
Molecular weight 389.09
XLogP 7.24
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CSc1c(Cl)ccc2c1n(CC(=O)O)c1c(c2=O)ccc(c1)C(C)(C)C
Isomeric SMILES CSc1c(Cl)ccc2c1n(CC(=O)O)c1c(ccc(c1)C(C)(C)C)c2=O
InChI InChI=1S/C20H20ClNO3S/c1-20(2,3)11-5-6-12-15(9-11)22(10-16(23)24)17-13(18(12)25)7-8-14(21)19(17)26-4/h5-9H,10H2,1-4H3,(H,23,24)
InChI Key CLGJCTXUWJLYHO-UHFFFAOYSA-N
References
1. Allen BK, Kulkarni M, Chamberlain B, Dwight T, Koh C, Samant R, Jernigan F, Rice J, Tan D, Li S et al.. (2022)
Design of a systemic small molecule clinical STING agonist using physics-based simulations and artificial intelligence.
biorxiv, Preprint. DOI: 10.1101/2022.05.23.493001